Analgesics (Pharmacies) - United Arab Emirates

Revenue in the Analgesics market is projected to reach US$59.13m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.36%, resulting in a market volume of US$80.49m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$6.17 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in United Arab Emirates is experiencing steady growth due to various factors such as increasing customer preferences for over-the-counter pain relief medications, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the United Arab Emirates have shown a growing preference for over-the-counter analgesics purchased from pharmacies. This can be attributed to several reasons. Firstly, the convenience of purchasing these medications from pharmacies allows customers to quickly and easily access pain relief without the need for a prescription. Secondly, the increasing awareness about self-care and the importance of managing minor ailments at home has led to a rise in the demand for over-the-counter analgesics. Lastly, the preference for analgesics from pharmacies can also be attributed to the trust customers place in the expertise and advice of pharmacists.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in United Arab Emirates is the growing demand for natural and herbal pain relief products. Customers are becoming more conscious about the ingredients in the medications they consume and are seeking alternatives that are perceived to be safer and have fewer side effects. This trend is driven by the increasing popularity of natural and holistic approaches to healthcare. As a result, pharmacies are expanding their product offerings to include a wider range of natural and herbal analgesics to cater to this growing demand. Another trend in the market is the rising popularity of online pharmacies. With the increasing penetration of internet and smartphones in United Arab Emirates, customers are increasingly turning to online platforms to purchase their analgesics. Online pharmacies offer the convenience of home delivery and a wide range of products to choose from. This trend is expected to continue as more customers embrace the digitalization of healthcare.

Local special circumstances: The United Arab Emirates has a high expatriate population, with people from various countries residing in the country. This diversity in the population leads to a demand for analgesics that cater to different cultural preferences and medical traditions. Pharmacies in United Arab Emirates are adapting to this demand by offering a wide range of analgesics from different countries and regions, ensuring that customers can find products that they are familiar with and trust.

Underlying macroeconomic factors: The United Arab Emirates has a strong healthcare system and a high standard of living, which contributes to the growth of the Analgesics (Pharmacies) market. The country has a well-developed infrastructure and a favorable business environment, attracting multinational pharmaceutical companies to establish a presence in the country. Additionally, the government of United Arab Emirates has been actively investing in the healthcare sector, which has led to the development of modern pharmacies and an increase in the availability of analgesics. In conclusion, the Analgesics (Pharmacies) market in United Arab Emirates is developing due to increasing customer preferences for over-the-counter pain relief medications, emerging trends such as the demand for natural and herbal products and the rise of online pharmacies, local special circumstances including a diverse population, and underlying macroeconomic factors such as a strong healthcare system and government investments in the sector.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.